SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001694187-19-000062
Filing Date
2019-08-06
Accepted
2019-08-06 09:17:04
Documents
70
Period of Report
2019-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q ntgn-20190630x10q.htm 10-Q 1431025
2 EXHIBIT 10.1 exhibit101.htm EX-10.1 16053
3 EXHIBIT 31.1 exhibit311.htm EX-31.1 14309
4 EXHIBIT 31.2 exhibit312.htm EX-31.2 14518
5 EXHIBIT 32.1 exhibit321.htm EX-32.1 9907
  Complete submission text file 0001694187-19-000062.txt   6150560

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT ntgn-20190630.xml EX-101.INS 1068521
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ntgn-20190630.xsd EX-101.SCH 48042
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT ntgn-20190630_cal.xml EX-101.CAL 71942
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT ntgn-20190630_def.xml EX-101.DEF 282921
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT ntgn-20190630_lab.xml EX-101.LAB 639502
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ntgn-20190630_pre.xml EX-101.PRE 417937
Mailing Address 40 ERIE STREET SUITE 110 CAMBRIDGE MA 02139
Business Address 40 ERIE STREET SUITE 110 CAMBRIDGE MA 02139 617-337-4701
Neon Therapeutics, Inc. (Filer) CIK: 0001694187 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38551 | Film No.: 191000602
SIC: 2836 Biological Products, (No Diagnostic Substances)